Inglese Marc J, Fleischer Alan B, Feldman Steven R, Balkrishnan Rajesh
Center for Dermatology Research and Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
J Dermatolog Treat. 2008;19(1):27-37. doi: 10.1080/09546630701729895.
The increasing recognition of the finite nature of health care resources has prompted the evaluation of the economic impact and value of medical interventions through pharmacoeconomic analysis. Despite the relevance and importance of pharmacoeconomics to dermatologic practice, there is a paucity of available literature on this topic. The purpose of this paper is to assess the number and quality of pharmacoeconomic studies applied to acne therapy as well as to provide a basic understanding of pharmacoeconomic analysis, its application to acne therapy, and the complex factors affecting the study of acne pharmacoeconomics.
A Medline search using the keywords acne, economics, cost-effectiveness, and pharmacoeconomics as well as a search of articles cited as references in the literature was used to identify pharmacoeconomic analyses for acne therapy. The quality of the studies was then evaluated by a standard model for evaluating the quality of cost-effectiveness studies.
Only six studies using a formal pharmacoeconomic evaluation of acne therapy were found in the literature. All were graded either good or excellent in quality.
There is a very limited amount of pharmacoeconomic data regarding acne therapy albeit good in quality thus far. Conducting further pharmacoeconomic studies could help maximize health care resources for the treatment of acne.
对医疗保健资源有限性的认识日益加深,促使人们通过药物经济学分析来评估医疗干预措施的经济影响和价值。尽管药物经济学对皮肤科实践具有相关性和重要性,但关于这一主题的现有文献却很匮乏。本文的目的是评估应用于痤疮治疗的药物经济学研究的数量和质量,并提供对药物经济学分析、其在痤疮治疗中的应用以及影响痤疮药物经济学研究的复杂因素的基本理解。
使用关键词痤疮、经济学、成本效益和药物经济学对Medline进行检索,并检索文献中作为参考文献引用的文章,以识别痤疮治疗的药物经济学分析。然后通过评估成本效益研究质量的标准模型来评估这些研究的质量。
文献中仅发现六项对痤疮治疗进行正式药物经济学评估的研究。所有研究的质量评级均为良好或优秀。
尽管到目前为止关于痤疮治疗的药物经济学数据质量良好,但数量非常有限。开展进一步的药物经济学研究有助于最大限度地利用医疗保健资源来治疗痤疮。